Franklin Biolabs

As a fully integrated preclinical contract research organization (CRO) at the forefront of genetic medicine innovation, we are a global leader with a rich legacy of scientific excellence and a proven record of advancing breakthrough therapies from concept to clinic. Our mission is to empower innovators by providing cutting-edge platform solutions and end-to-end support across the full development journey, from discovery through commercialization. Our dedicated and experienced team delivers seamless, superior customer service and expert project management, ensuring each partnership achieves its scientific and business goals efficiently. With deep expertise in genetic medicines and an unwavering commitment to innovation, we continue to help our clients turn pioneering ideas into life-changing therapies. Our expertise resides in three robust business units that work together seamlessly to support your entire project. CMC | Analytics • Research vector production and process development • Large-scale AAV manufacturing • Custom potency assays development, validation, and testing • Full suite of AAV GMP analytical testing (compendial, USP, etc.), multiple platform assays • Analytical testing for non-AAV products Preclinical | Translational • Rodents and a wide range of non-human primates with uninterrupted supply • Comprehensive pharmacology and toxicology assessments • Extensive experience across multiple routes of administration • 100% success rate in filing multiple INDs since 2019 • Full regulatory support Immunology | Bioanalytical • Clinical and non-clinical bioanalysis • Immunogenicity (ADA, Nab, ELISPOT) • Biodistribution and viral shedding • PK and biomarker analysis • Non-GLP, GLP, GCLP, CLIA Contact us today info@franklinbio.com to start a conversation about your upcoming project.